Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd announced that its Board of Directors, at a meeting held on 29th May 2025, approved the appointment of M/s Amit Dharmani & Associates, Practising Company Secretaries, as the Secretarial Auditor of the company for Financial Year 2024-25. Amit Dharmani & Associates is a firm of Company Secretaries established in 2017, based in Ujjain, providing corporate consultancy services. The disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The appointment is a routine compliance requirement under the Companies Act, and no relationship between the firm and the company's directors was disclosed.
This is a routine annual compliance filing with no material impact on shareholders or the stock price. The appointment of a secretarial auditor is a standard regulatory requirement and does not affect the company's financial position or operations.